Get the Stockscreener App
20.89
5.77%
1.14
After Hours:
20.89
Procept Biorobotics Corp stock is traded at $20.89, with a volume of 1.23M.
It is up +5.77% in the last 24 hours and down -28.19% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$19.75
Open:
$20.13
24h Volume:
1.23M
Relative Volume:
0.80
Market Cap:
$1.19B
Revenue:
$322.02M
Net Income/Loss:
$-102.47M
P/E Ratio:
-11.42
EPS:
-1.8295
Net Cash Flow:
$-80.57M
1W Performance:
-0.67%
1M Performance:
-28.19%
6M Performance:
-36.37%
1Y Performance:
-64.72%
1-Day Range:
$19.63
$21.00
1-Week Range:
$19.55
$21.88
52-Week Range:
$19.35
$62.17
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
20.89 | 1.19B | 322.02M | -102.47M | -80.57M | -1.8295 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Initiated | Robert W. Baird | Neutral |
| Feb-26-26 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-26-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-12-25 | Initiated | UBS | Buy |
| Dec-08-25 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
Pooja Sharma Net Worth (2026) - GuruFocus
Procept BioRobotics shares slide after Leerink downgrade cites rising competitive risks - MSN
Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT) - The Globe and Mail
PROCEPT BioRobotics stock stays guided by procedure demand - AD HOC NEWS
Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30 - marketscreener.com
PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 - Stocktwits
PRCTProcept BioRobotics Corp Dividends - Finviz
Truist cuts Procept BioRobotics stock rating on reimbursement concerns By Investing.com - Investing.com South Africa
Truist cuts Procept BioRobotics stock rating on reimbursement concerns - Investing.com
PROCEPT BioRobotics (PRCT) Gains On Coverage And Trial Progress, Is The Stock Still Cheap? - simplywall.st
PROCEPT BioRobotics (PRCT) Is Up 7.2% After WATER IV Milestones Spotlight Aquablation’s Oncology Potential – Has The Bull Case Changed? - simplywall.st
Evercore Initiates PROCEPT BioRobotics (PRCT) At “Outperform,” Cites Aquablation Growth Potential - Insider Monkey
Price to book forward of PROCEPT BioRobotics Corporation – NASDAQ:PRCT - TradingView
Price to sales forward of PROCEPT BioRobotics Corporation – NASDAQ:PRCT - TradingView
Enterprise value to EBITDA forward of PROCEPT BioRobotics Corporation – NASDAQ:PRCT - TradingView
Price to sales forward of PROCEPT BioRobotics Corp. – BX:PRCT - TradingView
Enterprise value to EBIT forward of PROCEPT BioRobotics Corp. – BX:PRCT - TradingView
Price to earnings forward of PROCEPT BioRobotics Corp. – BX:PRCT - TradingView
PRCT Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of PROCEPT BioRobotics Corp. – BX:PRCT - TradingView
PROCEPT BioRobotics(PRCT) Stock Options Chain | Quotes & News - Moomoo
PROCEPT BIOROBOTICS CORP (PRCT) Stock Chart - ChartMill
PROCEPT BioRobotics Corp. Actuals & Estimates (NASDAQ:PRCT) - TradingView
Here is Why PROCEPT BioRobotics (PRCT) is Amongst the Best Robotics and Automation Names Right Now - Insider Monkey
Evercore ISI initiates Procept BioRobotics stock with outperform rating - Investing.com UK
Evercore ISI initiates Procept BioRobotics stock with outperform rating By Investing.com - Investing.com Australia
5 Best Robotics and Automation Stocks to Invest In - Insider Monkey
PROCEPT BioRobotics (PRCT) Is Down 6.5% After Institutional Ownership Surges Past Shares Outstanding Has The Bull Case Changed? - simplywall.st
PROCEPT BioRobotics (PRCT) Stock Could Be 14% Undervalued After Growth Outlook Holds - simplywall.st
Transcript : PROCEPT BioRobotics Corporation Presents at 46th Annual William Blair Growth Stock Conference, Jun-02-2026 12 - marketscreener.com
Is PROCEPT BioRobotics Corporation (PRCT) A Good Stock To Buy Now? - Insider Monkey
Top 3 Health Care Stocks You'll Regret Missing In Q2 - Benzinga
Procept Biorobotics Corp (PRCT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Procept Biorobotics Corp (PRCT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Procept Biorobotics Corp (PRCT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Procept Biorobotics Corp (PRCT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Procept Biorobotics Corp (PRCT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Procept Biorobotics Corp (PRCT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Procept Biorobotics Corp (PRCT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Procept Biorobotics Corp (PRCT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Procept Biorobotics Corp (PRCT) Institutional Confidence - TradingKey
Why is Procept Biorobotics stock sliding today? By Investing.com - Investing.com South Africa
Why is Procept Biorobotics stock sliding today? - Investing.com UK
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):